Literature DB >> 11821684

Activity of dissolved mitomycin C after different methods of long-term storage.

M Georgopoulos1, C Vass, Z Vatanparast, A Wolfsberger, A Georgopoulos.   

Abstract

PURPOSE: The cytostatic substance mitomycin C (MMC) is used in trabeculectomy to enhance the success rate in problematic cases and is usually dissolved immediately before application, but only approximately 1% of the substance is needed for treatment. The authors evaluated different methods of long-time storage of MMC for a period of 6 months.
METHODS: MMC in concentrations of 0.02, 0.05, 0.1, 0.2, and 0.4 mg/mL was prepared at the local pharmaceutical department and stored at +22 degrees C (room temperature), +4 degrees C (refrigerator), -20 degrees C (freezer compartment), and -196 degrees C (liquid N2). The activity of MMC was evaluated with a microagar diffusion method (bioassay) after 30 minutes, and 1, 3, 7, 14, 30, 90, and 180 days for the different concentrations and storage methods.
RESULTS: There was no difference in the long-term stability of the investigated MMC concentrations. Ninety percent of the initial activity was preserved after storage at +22 degrees C for 1 week, -20 degrees C for 1 month, or +4 degrees C for 3 months. At 6 months the activities were 16%, 48%, and 78% of the initial values, respectively. The activity of MMC stored at -196 degrees C is not reduced after storage for 6 months.
CONCLUSIONS: Dissolved MMC can be stored in the refrigerator for up to 3 months without significant loss of activity. Storage at room temperature is not recommended. Costs of trabeculectomy can be reduced by storage of reconstituted solutions rather than dissolving MMC before each glaucoma surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821684     DOI: 10.1097/00061198-200202000-00004

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery.

Authors:  Sonia R Merritt; Gia Velasquez; Horst A von Recum
Journal:  Exp Eye Res       Date:  2013-07-31       Impact factor: 3.467

2.  Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.

Authors:  Alan L Myers; Yan-Ping Zhang; Jitesh D Kawedia; Ximin Zhou; Stacey M Sobocinski; Michael J Metcalfe; Mark A Kramer; Colin P N Dinney; Ashish M Kamat
Journal:  Drugs R D       Date:  2017-06

3.  Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages.

Authors:  George Tetz; Stuart M Brown; Yuhan Hao; Victor Tetz
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

Review 4.  A review of the efficacy of mitomycin C in glaucoma filtration surgery.

Authors:  Ahmed Al Habash; Leyla Ali Aljasim; Ohoud Owaidhah; Deepak P Edward
Journal:  Clin Ophthalmol       Date:  2015-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.